Jean-Louis Thomas

Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol

Martine Alhenc‐Gelas, Jean-Louis Thomas, Christilla Bachelot‐Loza et al. · Thrombosis and Haemostasis · 2011 · 97 citations

Familial hyperthyroidism without evidence of autoimmunity

Jean-Louis Thomas, Jacques Leclère, P Hartemann et al. · European Journal of Endocrinology · 1982 · 85 citations

Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol

Jacqueline Conard, Arnaud Basdevant, Jean-Louis Thomas et al. · Fertility and Sterility · 1995 · 74 citations

Hypertension, Hormonal Contraceptive, Health Policy +15

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women

Arnaud Basdevant, C Pélissier, Jacqueline Conard et al. · Contraception · 1991 · 61 citations

Metabolic Syndrome, Hormonal Contraceptive, Hemostatic Parameters +14

Inhibition of ovulation by NOMAC/E₂, a novel monophasic oral contraceptive combining nomegestrol acetate and 17<i>β</i>-oestradiol: A double-blind, randomised, dose-finding pilot study

Nathalie Chabbert‐Buffet, D Chassard, E. Ochsenbein et al. · The European Journal of Contraception & Reproductive Health Care · 2011 · 31 citations